BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 3084416)

  • 21. Human carcinoma cell lines produce biologically active leukemia inhibitory factor (LIF).
    Kamohara H; Sakamoto K; Ishiko T; Mita S; Masuda Y; Abe T; Ogawa M
    Res Commun Mol Pathol Pharmacol; 1994 Aug; 85(2):131-40. PubMed ID: 7994557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Response of primary human lung carcinomas to autocrine growth factors produced by a lung carcinoma cell line.
    Siegfried JM; Owens SE
    Cancer Res; 1988 Sep; 48(17):4976-81. PubMed ID: 3165706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on a purified human lung tumor-associated antigen.
    Braatz JA; Scharfe TR; Princler GL; McIntire KR
    Oncodev Biol Med; 1982; 3(2-3):169-77. PubMed ID: 7122254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cellular discriminants for a biological classification of human colon carcinoma.
    Drewinko B; Yang LY; Leibovitz A; Barlogie B; Lutz D; Jansson B; Stragand JJ; Trujillo JM
    Cancer Res; 1984 Oct; 44(10):4241-53. PubMed ID: 6467184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Profiles of prostaglandin biosynthesis in sixteen established cell lines derived from human lung, colon, prostate, and ovarian tumors.
    Hubbard WC; Alley MC; McLemore TL; Boyd MR
    Cancer Res; 1988 Sep; 48(17):4770-5. PubMed ID: 3409218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Morphologic characteristics, proliferation, and tumor marker expression of two human ovarian carcinoma cell lines in three-dimensional culture.
    Morimitsu Y; Yano H; Kojiro M
    Gynecol Oncol; 1993 Feb; 48(2):155-64. PubMed ID: 8428685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of DNA hypomethylation with expression of carcinoembryonic antigen in human colon carcinoma cells.
    Tran R; Kashmiri SV; Kantor J; Greiner JW; Pestka S; Shively JE; Schlom J
    Cancer Res; 1988 Oct; 48(20):5674-9. PubMed ID: 3167826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased calcitonin level in thyroid nodules without medullary carcinoma.
    Gibelin H; Essique D; Jones C; Levillain P; Maréchaud R; Kraimps JL
    Br J Surg; 2005 May; 92(5):574-8. PubMed ID: 15779075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunoreactive calcitonin production by human lung carcinoma cells in culture.
    Ellison M; Woodhouse D; Hillyard C; Dowsett M; Coombes RC; Gilby ED; Greenberg PB; Neville AM
    Br J Cancer; 1975 Sep; 32(3):373-9. PubMed ID: 1233082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Heterogeneity of immunoreactive calcitonin in the plasma of patients with bone marrow cancer].
    Moukhtar MS; Jullienne A; Taboulet J; Calmettes C; Raulais D; Milhaud G
    Pathol Biol (Paris); 1975 Dec; 23(10):809-14. PubMed ID: 772524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The ectopic secretion of calcitonin by lung and breast carcinomas.
    Coombes RC; Ellison ML; Easty GC; Hillyard CJ; James R; Galante L; Girgis S; Heywood L; MacIntyre I; Neville AM
    Clin Endocrinol (Oxf); 1976; 5 Suppl():387S-396S. PubMed ID: 1053252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterogeneity of immunoreactive calcitonin in human milk.
    Bucht E; Arver S; Sjöberg HE; Löw H
    Acta Endocrinol (Copenh); 1983 Aug; 103(4):572-6. PubMed ID: 6613498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Demonstration of immunoreactive calcitonin in sera and tissues of lung cancer patients.
    Luster W; Gropp C; Sostmann H; Kalbfleisch H; Havemann K
    Eur J Cancer Clin Oncol; 1982 Dec; 18(12):1275-83. PubMed ID: 6299749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcitonin secretion by continuous cultures of small cell carcinoma of the lung: incidence and immunoheterogeneity studies.
    Becker KL; Gazdar AF; Carney DN; Snider RH; Moore CF; Silva OL
    Cancer Lett; 1983 Mar; 18(2):179-85. PubMed ID: 6299519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunoreactive calcitonin production by a human promyelocytic leukemia cell line HL60.
    Oscier DG; Hillyard CJ; Arnett TR; MacIntyre I; Goldman JM
    Blood; 1983 Jan; 61(1):61-5. PubMed ID: 6571715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Value of serum calcitonin estimation in clinical oncology.
    Mulder H; Hackeng WH; Silberbusch J; den Ottolander GJ; van der Meer C
    Br J Cancer; 1981 Jun; 43(6):786-92. PubMed ID: 7248159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diurnal patterns of serum immunoreactive calcitonin in healthy males and in insulin dependent diabetics.
    Emmertsen K; Engkjaer Christensen S; Schmitz O; Marqversen J
    Clin Endocrinol (Oxf); 1983 Oct; 19(4):533-7. PubMed ID: 6685005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma immunoreactive calcitonin in lung cancer.
    Roos BA; Lindall AW; Baylin SB; O'Neil J; Frelinger AL; Birnbaum RS; Lambert PW
    Endocr Res Commun; 1979; 6(2):169-90. PubMed ID: 228926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolation of tumor-secreted products from human carcinoma cells maintained in a defined protein-free medium.
    Alderman EM; Lobb RR; Fett JW
    Proc Natl Acad Sci U S A; 1985 Sep; 82(17):5771-5. PubMed ID: 3862094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative studies of hamster calcitonin from pulmonary endocrine cells in vitro.
    Nylen ES; Linnoila RI; Snider RH; Tabassian AR; Becker KL
    Peptides; 1987; 8(6):977-82. PubMed ID: 3441449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.